乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02157 乐普生物-B

未开盘 08-13 16:08:27

9.750

+0.620

+6.79%

最高9.990	最低9.050	成交量3,360万
今开9.210	昨收9.130	日振幅10.30%
总市值175.89亿	流通市值170.63亿	总股本18.04亿
成交额3.22亿	换手率1.92%	流通股本17.50亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02157","market":"HK","secType":"STK","nameCN":"乐普生物-B","latestPrice":9.75,"timestamp":1755072507003,"preClose":9.13,"halted":0,"volume":33601000,"delay":0,"floatShares":1750000000,"shares":1804000000,"eps":-0.2659844902520956,"marketStatus":"未开盘","change":0.62,"latestTime":"08-13 16:08:27","open":9.21,"high":9.99,"low":9.05,"amount":321913660,"amplitude":0.102957,"askPrice":9.76,"askSize":2000,"bidPrice":9.75,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":-0.2659844902520956,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1755135000000},"marketStatusCode":0,"adr":0,"listingDate":1645545600000,"exchange":"SEHK","adjPreClose":9.13,"openAndCloseTimeList":[[1755048600000,1755057600000],[1755061200000,1755072000000]],"volumeRatio":0.7790846446138198,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02157","defaultTab":"news","newsList":[{"id":"2559674586","title":"港股异动 | 乐普生物-B(02157)涨超6% 自研TF ADC药物MRG004A纳入突破性治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2559674586","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559674586?lang=zh_cn&edition=full","pubTime":"2025-08-13 14:05","pubTimestamp":1755065144,"startTime":"0","endTime":"0","summary":"消息面上，8月11日，据国家药品监督管理局药品审评中心披露，乐普生物-B自主研发的TF ADC药物MRG004A被纳入突破性治疗药物，这一重要进展标志着乐普生物在ADC药物研发领域取得又一重大突破。MRG004A已分别在中、美取得IND批准，并获FDA授予孤儿药资格认定和快速通道资格，用于治疗胰腺癌。今年8月1日，乐普生物已启动MRG004A治疗胰腺癌的III期临床试验，期待MRG004A未来有望成为胰腺癌患者的全新治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02157","ADC","BK4080","BK4231","BK1161"],"gpt_icon":0},{"id":"2558562106","title":"ADC药物研发再结硕果！乐普生物-B(02157)MRG004A纳入突破性治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2558562106","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558562106?lang=zh_cn&edition=full","pubTime":"2025-08-11 18:00","pubTimestamp":1754906400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月11日，据国家药品监督管理局药品审评中心披露，乐普生物-B自主研发的TF ADC药物MRG004A被纳入突破性治疗药物，这一重要进展标志着乐普生物在ADC药物研发领域取得又一重大突破。MRG004A为生物制品，适应症为晚期胰腺癌。MRG004A已分别在中、美取得IND批准，并获FDA授予孤儿药资格认定和快速通道资格，用于治疗胰腺癌。今年8月1日，乐普生物已启动MRG004A治疗胰腺癌的III期临床试验，期待MRG004A未来有望成为胰腺癌患者的全新治疗选择。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","02157","BK1161","BK4080","ADC"],"gpt_icon":0},{"id":"2558113656","title":"每日卖空追踪 | 乐普生物-B 08月11日卖空量成交224.6万股，卖空比例为6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558113656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558113656?lang=zh_cn&edition=full","pubTime":"2025-08-11 16:30","pubTimestamp":1754901028,"startTime":"0","endTime":"0","summary":"乐普生物-B北京时间08月11日，涨1.43%，卖空量成交224.6万股%，较上一交易日减少46.68%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811171631a6df50f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811171631a6df50f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2558313653","title":"创新药行情扩散，医药子行业轮动开启！","url":"https://stock-news.laohu8.com/highlight/detail?id=2558313653","media":"华夏ETF","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558313653?lang=zh_cn&edition=full","pubTime":"2025-08-11 16:01","pubTimestamp":1754899270,"startTime":"0","endTime":"0","summary":"事件及点评8月6日，包括乐普生物、百济神州等头部医药企业发布2025年第二季度财务数据公告，半年度盈利转正。目前已进入中报披露高峰期，伴随国产创新药大额BD交易持续，利好政策逐步落实，医药底部子行业均呈现反转特征。7月医药生物的各二级行业中，所有子行业均同步上涨，医疗服务、化学制药、生物制品、医疗器械，轮动开启。在当前创新药持续估值修复带动下，中报数据验证有望催化估值修复行情向多环节扩散。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811160327a6df2cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811160327a6df2cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","688235","01093","ONC","02157","BK4526","600276","BK4139","BK4585","01276"],"gpt_icon":0},{"id":"1178257769","title":"港股创新药概念股全线回调，亚盛医药-B跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178257769","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178257769?lang=zh_cn&edition=full","pubTime":"2025-08-11 10:18","pubTimestamp":1754878692,"startTime":"0","endTime":"0","summary":"8月11日，港股创新药概念股全线回调，$亚盛医药-B(06855)$跌超8%，$乐普生物-B(02157)$、$康方生物(09926)$、$信达生物(01801)$-B、$同源康医药-B(02410)$跌超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157","HSTECH","IE00BPRC5H50.USD","06855","LU0348783233.USD","02410","01801","09926","BK1161","07226","06978","LU0348784397.USD","BK4614","YANG","LU0417516571.SGD","HSCEI","BK1589","09939","LU2488822045.USD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2558507623","title":"格隆汇沽空预警榜 | 8月8日","url":"https://stock-news.laohu8.com/highlight/detail?id=2558507623","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558507623?lang=zh_cn&edition=full","pubTime":"2025-08-10 02:15","pubTimestamp":1754763300,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日大市沽空比例为15.97%，过去两个月大市日均沽空比例为14.96%。其中，华夏恒生科技-U、联想集团-R、友邦保险-R沽空比率排名前三位，分别为100.00%、100.00%、100.00%。盈富基金、腾讯控股、阿里巴巴-W的沽空金额排名前三位，分别为29.37亿、14.81亿、10.88亿。狮腾控股、安硕中国、中旭未来的偏离值排名前三位，分别为6.38、5.51、5.43。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/10021552328330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HTCD.SI","00700","86618","02801","02562","03033","03199","81810","LU1439103000.SGD","09088","80992","LU0431992006.USD","MPNGY","02828","09766","83690","ALBmain","00546","83088","81299","01382","HXXD.SI","00314","LU0501845795.SGD","00376","LU0516423091.SGD","LU0293314216.USD","03111","MCHmain","MIUmain","09669","09688","09988","89988","09890","METmain","00013","XIACY","HBBD.SI","TCHmain","02453","03006","01810","02157","HMTD.SI","03690","BABA","LU2357305700.SGD","02800"],"gpt_icon":1},{"id":"2558503599","title":"创新药企上半年业绩频报喜行业步入发展新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2558503599","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558503599?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:39","pubTimestamp":1754703540,"startTime":"0","endTime":"0","summary":"多家创新药企在2025年上半年交出了亮眼的业绩报告，标志着行业正从依赖国内市场和仿制药模式向以原始创新和全球注册为核心的新阶段转变。甘李药业实现营收20.67亿元，同比增长57.18%，净利润6.04亿元，同比增长101.96%；百济神州首次半年度实现盈利，归母净利润4.50亿元，主要得益于自主研发产品如百悦泽®和安进授权产品的销售增长；乐普生物预计上半年利润不少于2400万元，首次实现盈利，收入增长主要来自许可合作及普特利单抗注射液的销售收入。此外，国家政策支持也推动了创新药的发展，包括鼓励商业健康保险扩大投资规模等措施。这些积极信号表明，中国创新药行业正在迎来新的发展机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094416973cf497&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094416973cf497&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","LU0588546209.SGD","02157","BK1161","06978","BK1588","ONC","LU2328871848.SGD","LU0307460666.USD","BK1500","603087","688235","06160","LU1969619763.USD"],"gpt_icon":0},{"id":"2557525518","title":"每日卖空追踪 | 乐普生物-B 08月08日卖空量成交299.8万股，卖空比例为6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557525518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557525518?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:30","pubTimestamp":1754641826,"startTime":"0","endTime":"0","summary":"乐普生物-B北京时间08月08日，跌2.99%，卖空量成交299.8万股%，较上一交易日增加52.57%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808175956a47d0434&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808175956a47d0434&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2557251923","title":"又一家创新药企首度盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2557251923","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557251923?lang=zh_cn&edition=full","pubTime":"2025-08-08 10:37","pubTimestamp":1754620620,"startTime":"0","endTime":"0","summary":"01两大引擎驱动盈利乐普生物成立于2018年，是一家专注于靶向治疗和肿瘤免疫治疗的创新型生物制药企业，在七年研发投入的积累下终于开始转化为财务回报。目前，该药已获批黑色素瘤、MSI-H/dMMR实体瘤两项适应症。此次合作的首付款及近期里程碑付款为公司今年上半年贡献显著现金流。该药是乐普生物基于其Hi-TOPi平台开发的一种新型拓扑异构酶I抑制剂GPC-3 ADC候选药物，具有全球首创新药潜力，目前正在进行I期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808105305a47c2cd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808105305a47c2cd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02157","06978","BK1161"],"gpt_icon":0},{"id":"2557159000","title":"最新，乐普生物宣布首次实现盈利！","url":"https://stock-news.laohu8.com/highlight/detail?id=2557159000","media":"药渡","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557159000?lang=zh_cn&edition=full","pubTime":"2025-08-08 07:32","pubTimestamp":1754609559,"startTime":"0","endTime":"0","summary":"昨日，乐普生物发布公告，公司截至2025年6月30日止六个月的未经审核综合管理账目及董事会现时所得数据的初步评估，预计公司将取得利润不少于人民币2400万元，上年同期则亏损约人民币1.97亿元。这是乐普生物首次实现盈利。2025年1月，乐普生物宣布，与ArriVent Biopharma,Inc.订立独家许可协议。据此协议，乐普生物向ArriVent授予独家许可，以在全球范围内开发及商业化集团创新型抗体偶联药物MRG007。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808085229a47beed1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808085229a47beed1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2557455931","title":"恒瑞125亿美元、石药超20亿美元小分子对外授权；赛诺菲、BMS又有新动态... | 一周交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2557455931","media":"创鉴汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557455931?lang=zh_cn&edition=full","pubTime":"2025-08-07 17:22","pubTimestamp":1754558551,"startTime":"0","endTime":"0","summary":"据创鉴汇不完全统计，7月28日至8月3日全球生物制药领域共披露25起交易事件，潜在交易总额近190亿美元。上周两起小分子对外授权案例引人注目。7月28日，恒瑞医药宣布和GSK达成协议，以潜在总额125亿美元将HRS-9821和至多11个项目授权给后者。紧随其后，石药集团也成功将其口服小分子药物GLP-1受体激动剂SYH2086授权给Madrigal Pharmaceuticals，此次交易金额最高可达20.75亿美元，包括1.2亿美元首付款。据悉，临床前数据显示，SYH2086具有体外激动活性，兼具降糖、减重效果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807180122a47ab094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807180122a47ab094&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287529.USD","LU0880133367.SGD","01276","LU0072913022.USD","LU1807302812.USD","LU1993786604.SGD","LU0315179316.USD","LU0326950275.SGD","02157","LU1152091754.HKD","BK1521","LU1152091168.USD","LU1008478684.HKD","LU0501845795.SGD","LU1960683339.HKD","IE00B543WZ88.USD","IE0008368742.USD","IE00B5MMRT66.SGD","BK1191","BK1515","LU1226287792.SGD","LU1226288170.HKD","IE0008369823.USD","IE00BZ08YT58.USD","01093","IE00BZ08YR35.GBP","LU1951186391.HKD","LU1226287875.USD","IE00B031HY20.USD","LU0140636845.USD","LU1226288253.USD","SG9999004220.SGD","LU0067412154.USD","IE00BZ08YS42.EUR","600276"],"gpt_icon":0},{"id":"2557589679","title":"乐普生物(02157.HK)首次半年度盈利！预计2025年中期利润超2400万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557589679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557589679?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:00","pubTimestamp":1754528400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MUCmain","CYB","CNHmain","MCNHmain","UCmain","BK1161","02157"],"gpt_icon":0},{"id":"2557586508","title":"强者恒强，ADC龙头盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2557586508","media":"阿基米德Biotech","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557586508?lang=zh_cn&edition=full","pubTime":"2025-08-07 08:04","pubTimestamp":1754525053,"startTime":"0","endTime":"0","summary":"乐普生物下一个重磅产品是MRG003，预计今年底有望成为全球首款获批上市的EGFR ADC。MRG003将引领鼻咽癌迈入ADC治疗新纪元。IO+ADC将长期成为肿瘤治疗的主线，乐普生物已坐稳头排位置。与中国在工程抗体的领导地位相匹配，ADC头部企业实现市值跃迁，成为这一轮生物科技资产重估浪潮的主线之一。乐普生物整个ADC布局也契合BD趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807080728a6d76f8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807080728a6d76f8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2557919376","title":"乐普生物-B首次实现盈利 预计上半年利润不少于2400万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557919376","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557919376?lang=zh_cn&edition=full","pubTime":"2025-08-06 17:47","pubTimestamp":1754473624,"startTime":"0","endTime":"0","summary":"格隆汇8月6日丨乐普生物-B公布，截至2025年6月30日止六个月，预计公司将录得利润不少于人民币2,400万元，而截至2024年6月30日止六个月的上年同期则亏损约人民币1.97亿元。这是公司首次实现盈利。的销售收入增长。有关上述许可安排的详情，请参阅本公司日期为2025年1月22日的公告。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806175143973731f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806175143973731f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2557459321","title":"乐普医疗的转型困境：心血管巨头能否靠″童颜针″破局？","url":"https://stock-news.laohu8.com/highlight/detail?id=2557459321","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557459321?lang=zh_cn&edition=full","pubTime":"2025-08-06 16:46","pubTimestamp":1754470000,"startTime":"0","endTime":"0","summary":"本文将深入分析乐普医疗面临的困境与可能的破局之路。截至2025年一季度末，乐普医疗应收账款高达18.57亿元，占最新年报净利润的752.09%，已逼近行业警戒值。面对业绩压力，乐普医疗管理层已采取多项自救措施。消息公布后，乐普医疗股价应声涨停，市场对公司的战略转型给予了初步肯定。研发管线储备丰富是乐普医疗在心血管领域的重要优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1754359317750732257","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["01358","BK1574","BK1161","09996","BK1600","BK1191","BK1222","BK1515","BK1593","00460","09997","BK1100","02291","02157","BK1583"],"gpt_icon":0},{"id":"2557837166","title":"每日卖空追踪 | 乐普生物-B 08月06日卖空量成交179.6万股，卖空比例为2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557837166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557837166?lang=zh_cn&edition=full","pubTime":"2025-08-06 16:30","pubTimestamp":1754469028,"startTime":"0","endTime":"0","summary":"乐普生物-B北京时间08月06日，涨4.61%，卖空量成交179.6万股%，较上一交易日增加8.65%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806172813a4786a63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806172813a4786a63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2557717346","title":"上市3日持续净流入！高人气港股创新药精选ETF(520690)涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2557717346","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557717346?lang=zh_cn&edition=full","pubTime":"2025-08-06 10:00","pubTimestamp":1754445614,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ZLAB","159992","HSCEI","02269","01530","09926","LU0348735423.USD","BK4139","BK1617","159938","LU0819121731.USD","01093","LU1226288170.HKD","HSTECH","LU0572944931.SGD","06978","BK4585","LU0823426480.USD","09939","IE00B543WZ88.USD","01801","LU1794554557.SGD","FDN","601377","LU1046422090.SGD","LU1226287875.USD","603259","LU1807302812.USD","LU0067412154.USD","LU0456846285.SGD","09688","IE00B031HY20.USD","LU0516422366.SGD","YANG","03692","06160","ONC","BK1583","BK0183","02157","01177","07226","BK0012","BK1141","02359","LU0072913022.USD","688235","LU0979878070.USD","02228","BK1191"],"gpt_icon":0},{"id":"2557398319","title":"每日卖空追踪 | 乐普生物-B 08月05日卖空量成交77.4万股，卖空比例为1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557398319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557398319?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:30","pubTimestamp":1754382627,"startTime":"0","endTime":"0","summary":"乐普生物-B北京时间08月05日，涨14.78%，卖空量成交77.4万股%，较上一交易日增加426.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805172014a6d43277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805172014a6d43277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2557356360","title":"乐普生物-B08月05日获主力加仓768.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557356360","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557356360?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:15","pubTimestamp":1754381743,"startTime":"0","endTime":"0","summary":"08月05日, 乐普生物-B股价涨14.78%，报收9.55元，成交金额5.4亿元，换手率3.36%，振幅13.34%，量比1.75。乐普生物-B今日主力资金净流入768.4万元，连续7日净流入，上一交易日主力净流入3093.4万元。该股近5个交易日上涨20.02%，主力资金累计净流入6858.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2.0亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805165533a6d42466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805165533a6d42466&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":1},{"id":"2557363147","title":"港股异动 | 乐普生物-B(02157.HK)涨幅扩大逾12% MRG004A启动III期临床 MRG007完成首例患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2557363147","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557363147?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:22","pubTimestamp":1754378520,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["III","02157","BK1161","BK4134"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lepubiopharma.com","stockEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":0.9777},{"period":"3month","weight":1.2159},{"period":"6month","weight":2.135},{"period":"1year","weight":2.2178},{"period":"ytd","weight":2.7214}],"compareEarnings":[{"period":"1week","weight":0.0282},{"period":"1month","weight":0.0583},{"period":"3month","weight":0.0921},{"period":"6month","weight":0.1323},{"period":"1year","weight":0.4914},{"period":"ytd","weight":0.2769}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"乐普生物科技股份有限公司是一家主要从事销售医药产品及新药研发的公司。该公司聚焦于肿瘤治疗领域，尤其是靶向治疗及免疫治疗。该公司致力于通过抗体药物偶联物（ADC）技术开发平台开发创新型ADC，填补癌症患者的临床需求缺口。该公司临床阶段候选药物包括靶向疗法药物及一种免疫治疗药物，它属于一种溶瘤病毒药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.073152},{"month":2,"riseRate":0.666667,"avgChangeRate":0.126327},{"month":3,"riseRate":0.25,"avgChangeRate":-0.056625},{"month":4,"riseRate":1,"avgChangeRate":0.229349},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007459},{"month":6,"riseRate":0.5,"avgChangeRate":-0.04556},{"month":7,"riseRate":0.5,"avgChangeRate":0.067498},{"month":8,"riseRate":0.5,"avgChangeRate":0.032014},{"month":9,"riseRate":0.666667,"avgChangeRate":0.142006},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.122076},{"month":11,"riseRate":0.333333,"avgChangeRate":0.044423},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.025701}],"exchange":"SEHK","name":"乐普生物-B","nameEN":"LEPU BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供乐普生物-B(02157)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"乐普生物-B,02157,乐普生物-B股票,乐普生物-B股票老虎,乐普生物-B股票老虎国际,乐普生物-B行情,乐普生物-B股票行情,乐普生物-B股价,乐普生物-B股市,乐普生物-B股票价格,乐普生物-B股票交易,乐普生物-B股票购买,乐普生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供乐普生物-B(02157)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}